N-alkylated peptides having antiangiogenic activity
US6777535B1 · kind B1 · utility
0Cited by
4References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2000 |
| Grant date | Aug 17, 2004 |
| Priority date | — |
| Expiry date | Jun 28, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
N-Alkylated peptides of formula (I)Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11  (I),are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.